BE678216A - - Google Patents

Info

Publication number
BE678216A
BE678216A BE678216DA BE678216A BE 678216 A BE678216 A BE 678216A BE 678216D A BE678216D A BE 678216DA BE 678216 A BE678216 A BE 678216A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE678216A publication Critical patent/BE678216A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE678216D 1965-03-23 1966-03-22 BE678216A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44220565A 1965-03-23 1965-03-23
US57654966A 1966-09-01 1966-09-01
US734770A 1970-01-28 1970-01-28

Publications (1)

Publication Number Publication Date
BE678216A true BE678216A (de) 1966-09-22

Family

ID=27358345

Family Applications (1)

Application Number Title Priority Date Filing Date
BE678216D BE678216A (de) 1965-03-23 1966-03-22

Country Status (5)

Country Link
US (1) US3609152A (de)
BE (1) BE678216A (de)
DE (1) DE1620127C3 (de)
FR (1) FR5267M (de)
GB (3) GB1062357A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2198751A1 (de) * 1972-09-09 1974-04-05 Pfizer

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847693A1 (de) * 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
US4625026A (en) * 1982-12-30 1986-11-25 Biomeasure, Inc. 2-amino-4-oxo-tricyclicpyrimidines having antiviral activities against herpes simplex virus type II infections
JPS6442472A (en) * 1987-08-10 1989-02-14 Kanebo Ltd Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient
US4877790A (en) * 1987-12-15 1989-10-31 Kanebo Limited Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
TW334434B (en) * 1995-05-16 1998-06-21 Kanebo Ltd Novel quinazoline compound and anti-tumor agent
AU2769897A (en) * 1996-05-07 1997-11-26 Basf Aktiengesellschaft Imidazoquinazolines, agents containing them and their use to combat fungi and animal pests
CN1237060C (zh) * 2001-01-02 2006-01-18 弗·哈夫曼-拉罗切有限公司 用作α1A/B肾上腺素能受体拮抗剂的喹唑酮衍生物
US6900220B2 (en) 2001-01-02 2005-05-31 Syntex (U.S.A.) Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
EP1389224B1 (de) * 2001-05-14 2010-01-13 Omnova Soltions Inc Polymere tenside aus zyklischen monomeren, die fluorierte carbongruppen am ende enthalten
EP1398032A1 (de) * 2002-09-10 2004-03-17 PheneX Pharmaceuticals AG 4-Oxochinazoline, die an den LXR Kernrezeptor binden
EP1407774A1 (de) * 2002-09-10 2004-04-14 LION Bioscience AG 2-Amino-4-chinazolinone, die an den LXR Kernrezeptor binden
DK1557414T3 (da) 2002-10-01 2012-05-29 Mitsubishi Tanabe Pharma Corp IsoquinoIin-forbindelser og medicinsk anvendelse deraf
ES2376166T3 (es) 2002-11-22 2012-03-09 Mitsubishi Tanabe Pharma Corporation Compuestos de isoquinolina y su uso medicinal.
KR101118582B1 (ko) 2003-11-20 2012-02-27 얀센 파마슈티카 엔.브이. 폴리(ａｄｐ-리보스)폴리머라제 저해제로서의 6-알케닐 및6-페닐알킬 치환된 2-퀴놀리논 및 2-퀴녹살리논
EP1709011B1 (de) 2003-11-20 2015-07-29 Janssen Pharmaceutica NV 7-phenylalkylsubstituierte 2-chinolinone und 2-chinoxalinone als inhibitoren von poly(adp-ribose)polymerase
UA85593C2 (uk) 2004-06-30 2009-02-10 Янссен Фармацевтика Н.В. Похідні хіназолінону як інгібітори parp
MXPA06014541A (es) 2004-06-30 2007-03-23 Janssen Pharmaceutica Nv Derivados de quinazolindiona como inhibidores de la poli(adp-ribosa) polimerasa.
EA014955B1 (ru) 2004-06-30 2011-04-29 Янссен Фармацевтика Н. В. Производные фталазина в качестве ингибиторов parp
EP2602259A3 (de) * 2005-02-18 2014-09-10 Mitsubishi Tanabe Pharma Corporation Salz des Prolinderivats, Solvat davon und Herstellungsverfahren dafür
BRPI0710083A2 (pt) 2006-03-31 2011-08-02 Janssen Pharmaceutica Nv entidade quìmica benzoimidazol-2-il pirimidina e pirazina, composição farmacêutica e uso destas
AU2008223793B2 (en) 2007-03-08 2012-08-23 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP and TANK inhibitors
WO2009053373A1 (en) 2007-10-26 2009-04-30 Janssen Pharmaceutica Nv Quinolinone derivatives as parp inhibitors
US8889866B2 (en) 2008-03-27 2014-11-18 Janssen Pharmaceutica, Nv Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
WO2009118384A1 (en) 2008-03-27 2009-10-01 Janssen Pharmaceutica Nv Quinazolinone derivatives as tubulin polymerization inhibitors
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
EP2303869A2 (de) * 2008-06-30 2011-04-06 Janssen Pharmaceutica, N.V. Verfahren zur herstellung von benzimidazol-2-ylpyrimidinderivaten
JP5752601B2 (ja) 2008-12-08 2015-07-22 ブイエム ファーマ エルエルシー タンパク質受容体チロシンキナーゼ阻害薬の組成物
US8987444B2 (en) * 2010-01-18 2015-03-24 Msn Laboratories Private Limited Process for the preparation of amide intermediates and their use thereof
WO2012131706A1 (en) * 2011-03-20 2012-10-04 Cadila Healthcare Limited Amorphous form of vilazodone hydrochloride and process for its preparation
DE102011113749A1 (de) * 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
CN104271573A (zh) * 2011-09-30 2015-01-07 詹森药业有限公司 (1-(4-氟苯基)-1h-吲哚-5-基)-(3-(4-(噻唑-2-羰基)哌嗪-1-基)氮杂环丁-1-基)甲酮的结晶盐酸盐及其治疗疼痛和代谢紊乱的用途
CN104302178B (zh) 2012-03-15 2018-07-13 西建卡尔有限责任公司 表皮生长因子受体激酶抑制剂的固体形式
EP2825042B1 (de) 2012-03-15 2018-08-01 Celgene CAR LLC Salze eines epidermalen wachstumsfaktor-rezeptor-kinase-hemmers
US20130261134A1 (en) * 2012-03-30 2013-10-03 Boehringer Ingelheim International Gmbh Mesylate salt forms of a potent hcv inhibitor
CA2900012A1 (en) 2013-02-08 2014-08-14 Celgene Avilomics Research, Inc. Erk inhibitors and uses thereof
WO2014138368A1 (en) 2013-03-06 2014-09-12 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
US8999992B2 (en) 2013-03-15 2015-04-07 Vm Pharma Llc Crystalline forms of tryosine kinase inhibitors and their salts
MX369738B (es) * 2013-12-03 2019-11-20 Amgen Inc Formas cristalinas de sales de n-(4-((3-(2-amino-4-pirimidinil)-2- piridinil)oxi)fenil)-4-(4-metil-2-tienil)-1-ftalazinamina y usos de las mismas.
TW201613892A (en) 2014-08-13 2016-04-16 Celgene Avilomics Res Inc Forms and compositions of an ERK inhibitor
MX2017003439A (es) 2014-09-17 2017-12-04 Mundipharma International Corporation Ltd Formas cristalinas de inhibidores de tirosina cinasa y sus sales.
CN112645932B (zh) * 2016-03-22 2022-01-14 江苏豪森药业集团有限公司 Egfr抑制剂游离碱或其酸式盐的多晶型、其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274194A (en) * 1963-03-29 1966-09-20 Miles Lab Quinazolinedione derivatives
US3301855A (en) * 1963-04-22 1967-01-31 Ciba Geigy Corp Derivatives of 4-nu-(2-nu, nu-dimethylaminolower alkyl)-amino quinazoline
GB1053063A (de) * 1963-05-18
US3257400A (en) * 1964-06-10 1966-06-21 Searle & Co 2-amino-5, 6-dihydrobenzo[h]quinazolin-4(3h)-one and congeners

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2198751A1 (de) * 1972-09-09 1974-04-05 Pfizer

Also Published As

Publication number Publication date
GB1174272A (en) 1969-12-17
US3609152A (en) 1971-09-28
DE1620127C3 (de) 1974-10-10
GB1062357A (en) 1967-03-22
GB1174273A (en) 1969-12-17
DE1620127B2 (de) 1974-01-17
FR5267M (de) 1967-07-31
DE1620127A1 (de) 1970-03-12

Similar Documents

Publication Publication Date Title
FR5267M (de)
JPS4910712B1 (de)
FR1599670A (de)
FR2146690A6 (de)
JPS43874Y1 (de)
JPS4218198Y1 (de)
JPS4219245Y1 (de)
JPS4316607Y1 (de)
JPS4410266Y1 (de)
JPS4411645Y1 (de)
JPS4515425Y1 (de)
JPS4518056Y1 (de)
NL6618103A (de)
BE690457A (de)
NL6606510A (de)
NL6604560A (de)
NL6515620A (de)
NL6506540A (de)
NL6501259A (de)
BE674400A (de)
SE320389B (de)
SE322196B (de)
BE673353A (de)
BE673414A (de)
BE674514A (de)